PF-Atlas › Clinical Trials › NCT00846573
Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders
Hyperpolarized Helium-3 · Not specified
Registry ID
NCT00846573
Phase
Not specified
Status
Terminated
Drug / intervention
Hyperpolarized Helium-3
Sponsor
University of Massachusetts, Worcester
Start
2008-11
Enrollment
14
Locations
1
About this trial
The purpose of this study is to test the efficacy of Hyperpolarized Helium-3 gas in MR imaging in COPD, asthmatics, CF and healthy volunteers.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT00846573 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.